Clinical Trial Update: A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating teplizumab versus placebo in participants aged 1 to 25 with Stage 3 Type 1 Diabetes; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• TZIELD (TEPLIZUMAB-MZWV)

Snippet

Sponsor: Sanofi | Conditions: Type 1 Diabetes Mellitus | Phase 3 | Status: RECRUITING